We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Infusion

News List

QUZYTTIR™ shows promise in preventing infusion related reactions europeanpharmaceuticalreview
March 09, 2021
Phase II data suggests intravenous QUZYTTIR™ cetirizine hydrochloride can decrease infusion reactions to anti-CD20 antibody treatments and reduce time to discharge after therapy.
FDA Approves Myxredlin Insulin for IV Infusion americanpharmaceuticalreview
July 23, 2019
Baxter International announced the U.S. Food and Drug Administration (FDA) approval of Myxredlin (Insulin Human in 0.9% Sodium Chloride Injection).
Regular infusions of a novel antibody may suppress HIV for four months europeanpharmaceuticalreview
April 19, 2019
Regular infusions of a novel antibody may suppress HIV for four months.